ArticleJournal of virology2026
Regulation of HPV-16 infection by ubiquitination of the L1 major capsid protein.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A novel approach to HPV16 VLP construction and production with improved accessibility and particle sorting potential.Frontiers in molecular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The L1 major capsid protein of the papillomavirus is critical for both viral assembly and entry into host cells, but the impact of its post-translational modifications on the HPV life cycle remains poorly understood. In this study, we show, for the first time, that HPV16 L1 is ubiquitinated at several conserved lysine residues (K20, K64, K152, K217, K437, K452, and K454) identified by mass spectrometry. Mutations at K64 and K152 prevent the formation of pseudovirions, while other lysine mutants permit the formation of pseudovirions, but these display lower infectivity in several epithelial cell lines. Pre-incubation of HPV-16 pseudovirions with an anti-ubiquitin antibody also significantly reduces their infectivity. Ubiquitination does not appear to be essential for virus attachment, but K452 and K454 are critical for efficient infectious entry, and they impact intracellular trafficking and processing. Taken together, these results demonstrate a critical link between the ubiquitin-conjugating system and HPV capsid proteins and highlight the potential and novel role of L1 protein ubiquitination in regulating different stages of the HPV infection. IMPORTANCE: Despite vaccination efforts, HPV infection remains a major global health threat. Understanding how the virus interacts with human cells is therefore crucial for the development of new therapeutic strategies. This study reveals a previously unknown role of ubiquitination of the HPV16 L1 capsid protein, which is critical for both virus assembly and infectious entry. The Ub-acceptor sites identified by mass spectrometry are highly conserved between different papillomavirus types (HPV-16 and BPV-1), indicating a conserved function within the L1 protein and the viral capsid. We show that L1 ubiquitination plays important but diverse roles during HPV infection, potentially influencing both correct intracellular virus trafficking and HPV virion assembly. Overall, these studies demonstrate a critical link between the ubiquitin-conjugating system and HPV capsid proteins and highlight the novel role of ubiquitination during HPV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.